Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
2022 Standout
Works of J. Kukler being referenced
Association of food allergy and atopic dermatitis exacerbations
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Kukler | 247 | 106 | 182 | 115 | 11 | 379 | |
| Carlotta Povesi Dascola | 194 | 90 | 135 | 95 | 11 | 391 | |
| Barbara Cuomo | 225 | 56 | 115 | 92 | 16 | 424 | |
| Christina B. Johns | 209 | 43 | 145 | 47 | 7 | 354 | |
| F Martín-Muñoz | 346 | 115 | 111 | 22 | 8 | 408 | |
| E Buchman | 186 | 46 | 188 | 102 | 14 | 412 | |
| S. M. Nasser | 263 | 83 | 164 | 39 | 9 | 361 | |
| Janet R. Roberts | 304 | 96 | 132 | 39 | 10 | 385 | |
| Catrin Furuhjelm | 109 | 33 | 143 | 62 | 8 | 403 | |
| Marianne Søndergaard Khinchi | 374 | 223 | 256 | 33 | 8 | 413 | |
| Hanne H. Villesen | 284 | 138 | 353 | 105 | 11 | 457 |
All Works
Loading papers...